Table 2 Statistical analysis on HMCLs treated with BVDV
From: Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Mean ± SD % of dead cells BVDV vs. CNT | p value | ||
|---|---|---|---|
JJN3 | 24 h | 18.5 ± 2.5% vs. 5.3 ± 1% | 0.00005 |
48 h | 44.2 ± 9.8% vs. 11.3 ± 1.5% | 0.0002 | |
72 h | 54.3 ± 12.8% vs. 21.5 ± 1.9% | 0.002 | |
OPM2 | 24 h | 28 ± 1% vs. 9 ± 1.4% | < 0.00001 |
48 h | 48 ± 5.6% vs. 13 ± 2.7% | 0.00002 | |
72 h | 58 ± 1.7% vs. 22 ± 1.8% | < 0.00001 | |
MM1.S | 24 h | 9 ± 1.8% vs. 4 ± 1.7% | 0.012 |
48 h | 12 ± %3 vs. 5 ± 1.2% | 0.005 | |
72 h | 20 ± 1.7% vs. 4 ± 0.5% | < 0.00001 | |
NCI-H929 | 24 h | 10 ± 0.01 vs. 8 ± 0.01 | 0.16553 |
48 h | 26 ± 2.6% vs. 10 ± 1.2% | 0.00004 | |
72 h | 76 ± 2.5% vs. 10.5 ± 0.5% | < 0.00001 | |